Results 91 to 100 of about 4,461,121 (140)

Fumarate hydratase suppresses glioblastoma progression by restricting fumarate-mediated succination of TRIM17. [PDF]

J Biol Chem
Ju Q, Hu Y, Gong C, Wu R, Shen M, Wang X, Tang X, Shen J, Sun C.   +8 more
europepmc   +1 more source

Prolactin-Releasing Hormone Receptor (PRLHR) enhances radiosensitivity and exacerbates DNA damage in glioblastoma post-irradiation by inhibiting Y-box-binding protein-1 (YBX1) nuclear translocation: a novel perspective on precision radiotherapy. [PDF]

Mol Biomed
Qiu Y, Zhang J, Liu J, Wang Z, Ma Z, Wang M, Wang Q, Liu X, Yan D, Zhang Z.   +9 more
europepmc   +1 more source

Harnessing Repurposed Drugs to Enhance Temozolomide Efficacy in Glioblastoma. [PDF]

Cancer Rep (Hoboken)
Nakhaei A, Taghavi A, Afshari AR, Davoudi F, Gheybi E, Jalili-Nik M.   +5 more
europepmc   +1 more source

Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth. [PDF]

Front Oncol
Guo G, Sun Y, Hong R, Lu Y, Chen X, Zhao L, Li C, Liu Y, Huang Q.   +8 more
europepmc   +1 more source

IGSF3 drives acquired temozolomide resistance in glioblastoma through ASNS-dependent asparagine biosynthesis. [PDF]

J Biol Chem
Li J, Lu H, Xu Q, Yin Y, Pu Z, Huang J, Wang J.   +6 more
europepmc   +1 more source

Self-assembled biomimetic nanocomposite integrating defect-enhanced piezoelectricity with NIR-II fluorescence and MR imaging for ultrasound-triggered piezo/chemodynamic therapy of subcutaneous glioma. [PDF]

J Nanobiotechnology
Hasan I, Ullah Z, Wang F, Wang L, Yan Y, Gong T, Madni M, Mondal D, Qu H, Roy J, Zhang Y, Roy S, Guo B, Chang C.   +13 more
europepmc   +1 more source

IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma. [PDF]

Mater Today Bio
Schietinger M, Sahnoun SEM, Krug EJ, Loewe PN, Alimonti P, van der Vorst EPC, Mammadbayli N, Morgenroth A, Müller D, Buhl EM, Gad AA, Neumaier B, Mottaghy FM, Schulz JB, Vallis KA, Habib P.   +15 more
europepmc   +1 more source

<i>miR-506-5p</i> targets <i>MAPK7</i> to impede glioma growth and invasion through suppressing epithelial-mesenchymal transition and matrix metalloproteinases. [PDF]

Transl Cancer Res
Sun T, Wang G, Chen Y, Geng X, Zhu X, Zhou H.   +5 more
europepmc   +1 more source

TRIM47 promotes cell viability, cell cycle progression, metabolic reprogramming, and inhibits apoptosis of glioma via the NF-κB signaling pathway. [PDF]

Transl Cancer Res
Lai X, Zhu J, Jia H, Zhang P, Wang B, Tang Y, Ran Q.   +6 more
europepmc   +1 more source